These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18362264)

  • 1. CSF analysis in suspected MS: do bands aid?
    Hintzen RQ; Giovannoni G
    Neurology; 2008 Mar; 70(13 Pt 2):1059-60. PubMed ID: 18362264
    [No Abstract]   [Full Text] [Related]  

  • 2. 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system.
    Mehling M; Kuhle J; Regeniter A
    Neurologist; 2008 Jan; 14(1):60-5. PubMed ID: 18195662
    [No Abstract]   [Full Text] [Related]  

  • 3. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
    Tintoré M; Rovira A; Río J; Tur C; Pelayo R; Nos C; Téllez N; Perkal H; Comabella M; Sastre-Garriga J; Montalban X
    Neurology; 2008 Mar; 70(13 Pt 2):1079-83. PubMed ID: 17881717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis.
    Awad A; Hemmer B; Hartung HP; Kieseier B; Bennett JL; Stuve O
    J Neuroimmunol; 2010 Feb; 219(1-2):1-7. PubMed ID: 19782408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes.
    Sandberg-Wollheim M; Olsson T
    Mult Scler; 2013 May; 19(6):714-6. PubMed ID: 23658235
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis.
    Thompson EJ; Freedman MS
    Adv Neurol; 2006; 98():147-60. PubMed ID: 16400832
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
    Imrell K; Greiner E; Hillert J; Masterman T
    J Neuroimmunol; 2009 May; 210(1-2):128-30. PubMed ID: 19327846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological diagnostic criteria in multiple sclerosis].
    Dimitri D
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):968-73. PubMed ID: 11787362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
    Bednárová J; Stourac P; Adam P
    Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making the diagnosis of multiple sclerosis.
    Birnbaum G
    Adv Neurol; 2006; 98():111-24. PubMed ID: 16400830
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome.
    Ferraro D; Simone AM; Bedin R; Galli V; Vitetta F; Federzoni L; D'Amico R; Merelli E; Nichelli PF; Sola P
    J Neuroimmunol; 2013 Apr; 257(1-2):76-81. PubMed ID: 23434160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
    Villar LM; Espiño M; Roldán E; Marín N; Costa-Frossard L; Muriel A; Alvarez-Cermeño JC
    Mult Scler; 2011 Jun; 17(6):690-4. PubMed ID: 21436320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeing injectable MS therapies differently: they are more similar than different.
    Fox RJ; Arnold DL
    Neurology; 2009 Jun; 72(23):1972-3. PubMed ID: 19439722
    [No Abstract]   [Full Text] [Related]  

  • 15. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    Berg-Hansen P; Vandvik B; Fagerhol M; Holmøy T
    J Neuroimmunol; 2009 Nov; 216(1-2):98-102. PubMed ID: 19800696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns.
    Huttner HB; Schellinger PD; Struffert T; Richter G; Engelhorn T; Bassemir T; Mäurer M; Garcia M; Schwab S; Köhrmann M; Doerfler A
    J Neurol; 2009 Jul; 256(7):1121-5. PubMed ID: 19252765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis mimics.
    Herndon RM
    Adv Neurol; 2006; 98():161-6. PubMed ID: 16400833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
    Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP
    Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis and recurrent disseminated encephalomyelitis are different diseases.
    Poser CM
    Arch Neurol; 2008 May; 65(5):674; author reply 674-5. PubMed ID: 18474749
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
    Imrell K; Landtblom AM; Hillert J; Masterman T
    Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.